ORPHA:758
Pseudoxanthoma elasticum
Also known as: Gronblad-Strandberg-Touraine syndrome · PXE
Publications
4,115
94.8th percentile
Trials
18
Interventional, condition-specific
Researchers
948
Distinct authors in sample
Gene link
ABCC6
Definitive
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A rare, genetic, disease with connective tissue and eye involvement, characterized by ectopic mineralization and fragmented elastic fibers in the skin, retina and vascular walls.
How rare: 1-9 / 100 000 — about one to nine people per hundred thousand.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0009925
- MeSH:D011561
- OMIM:264800
- NCIT:C85036
Additional Mondo synonyms (2)
AR inherited pseudoxanthoma elasticum · Gronblad-Strandberg syndrome
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Definitive — ABCC6
- LiteraturePresent
4,115 matched papers (1,616 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
18 matched on ClinicalTrials.gov (6 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (ABCC6).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
4,115
4,115 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
4,115 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
1,616 in the last 10 years · medium confidence · 94.8th percentile (publications denominator)
Phrase hits: 4,115 · MeSH hits: 0
Who's working on it?
948
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Pfau K15 papers · 2026
From the Department of Ophthalmology (K.R, P.H, F.H, K.P), University of Bonn, Bonn, Germany; Department of Ophthalmology (M.P, K.P), University of Basel, Basel, Switzerland. Electronic address: Kristina.Pfau@ukbonn.de.
Papers in Europe PMC - 02Pfau M13 papers · 2026
Institute of Molecular and Clinical Ophthalmology Basel (M.P), Basel, Switzerland; Department of Ophthalmology (M.P, K.P), University of Basel, Basel, Switzerland.
Papers in Europe PMC - 03Spiering W12 papers · 2026
Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands.
Papers in Europe PMC - 04de Jong PA11 papers · 2026
Department of Radiology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Papers in Europe PMC - 05Martin L10 papers · 2026
PXE Reference Center, MAGEC Nord, Angers University Hospital, 49000 Angers, France.
Papers in Europe PMC - 06Holz FG8 papers · 2025
From the Department of Ophthalmology (K.R, P.H, F.H, K.P), University of Bonn, Bonn, Germany.
Papers in Europe PMC - 07Raming K7 papers · 2025
From the Department of Ophthalmology (K.R, P.H, F.H, K.P), University of Bonn, Bonn, Germany.
Papers in Europe PMC - 08Leftheriotis G6 papers · 2026
University Côte d'Azur, CNRS, LP2M, Labex ICST, 06107 Nice, France.
Papers in Europe PMC - 09van Leeuwen R6 papers · 2026
Ophthalmology Department, University Medical Center Utrecht, Utrecht, the Netherlands.
Papers in Europe PMC - 10Vanakker OM6 papers · 2026
Center for Medical Genetics, Ghent University Hospital, 9000 Ghent, Belgium.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
18
interventional trials for this specific condition
18 interventional trials matched this specific condition name; 6 currently recruiting in our sample.
Data as of 27 July 2026
18 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 94.1th percentile).
medium confidence · 94.1th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
18 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT04868578·RECRUITING·PPI Supplementation to Fight ECtopIc Calcification in PXE
Conditions: Pseudoxanthoma Elasticum·Matched via name phrase
- NCT05832580·RECRUITING·The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum
Conditions: Pseudoxanthoma Elasticum·Matched via name phrase
- NCT05734196·RECRUITING·The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency
Conditions: Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency · Autosomal Recessive Hypophosphatemic Rickets · Generalized Arterial Calcification of Infancy · ATP-Binding Cassette Subfamily C Member 6 Deficiency·Matched via name phrase
- NCT07006649·RECRUITING·CHOPXE - Analysis of Choriocapillaris Flow Deficits in Patients With Pseudoxanthoma Elasticum
Conditions: Pseudoxanthoma Elasticum · Tomography, Optical Coherence · Retinal Disease·Matched via name phrase
- NCT06462547·RECRUITING·ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency
Conditions: Gene Mutations · Pseudoxanthoma Elasticum · Arterial Calcification · Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency·Matched via name phrase
- NCT07323082·RECRUITING·Purinergic Compounds in Pseudoxanthoma Elasticum
Conditions: Pseudoxanthoma Elasticum·Matched via name phrase
Observational and natural-history studies
15 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07048106·RECRUITING·Progression Assessment of PXE-associated Alterations
Conditions: Pseudoxanthoma Elasticum · Angioid Streaks · Peau d'Orange · Grönblad-Stranberg Disease (Pseudoxanthoma Elasticum)·Matched via name phrase
- NCT06636344·RECRUITING·Impact of Optimized Recruitment and Follow-up of Patients With Pseudoxanthoma Elasticum (PXE)
Conditions: Pseudoxanthoma Elasticum·Matched via name phrase
- NCT06302439·RECRUITING·PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency
Conditions: Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency · ATP-Binding Cassette Subfamily C Member 6 Deficiency·Matched via recall expansion
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Pseudoxanthoma elasticum" OR "Gronblad-Strandberg-Touraine syndrome" OR "AR inherited pseudoxanthoma elasticum" OR "Gronblad-Strandberg syndrome"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Pseudoxanthoma elasticum" OR "Gronblad-Strandberg-Touraine syndrome" OR "AR inherited pseudoxanthoma elasticum" OR "Gronblad-Strandberg syndrome" OR "ABCC6"
Recall-expansion terms: ABCC6
Interventional trials matched via: phrase, recall-expansion (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 18 interventional · 15 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase, recall-expansion; with hits: phrase, recall-expansion
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: PXE
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T15:14:33.899Z
